Publications by authors named "Grant Hunter"

Claim this Profile
C
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma.
Jessica L Fleming, Stephanie L Pugh, Susan M Chang, Joseph P McElroy, Aline P Becker, Grant K Hunter

Int J Radiat Oncol Biol Phys· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825.
Joshua D Strauss, Mark R Gilbert, Minesh Mehta, Ang Li, Renke Zhou, Grant K Hunter

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline polymorphisms in associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman, Grant K Hunter

Neurooncol Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
Nirav Patil, Eashwar Somasundaram, Kristin A Waite, Justin D Lathia, Mitchell Machtay, Grant K Hunter

J Neurooncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, Mark R Gilbert, Merideth M Wendland, Grant Hunter

Neuro Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
Erica H Bell, Peixin Zhang, Edward G Shaw, Jan C Buckner, Geoffrey R Barger, Grant K Hunter

J Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525.
H Ian Robins, Jens Eickhoff, Mark R Gilbert, Terri S Armstrong, Wenyin Shi, Grant K Hunter

Neurooncol Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.
Deborah T Blumenthal, Minhee Won, Minesh P Mehta, Mark R Gilbert, Paul D Brown, Grant K Hunter

Neuro Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
Susan Chang, Peixin Zhang, J Gregory Cairncross, Mark R Gilbert, Jean-Paul Bahary, Grant Hunter

Neuro Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.
Priyanka Bhateja, Matthew C Ward, Grant H Hunter, John F Greskovich, Chandana A Reddy

Head Neck· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma.
Grant K Hunter, Ehsan H Balagamwala, Shlomo A Koyfman, Trevor Bledsoe, Lawrence J Sheplan

Pract Radiat Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients.
Grant K Hunter, Kristin Brockway, Chandana A Reddy, Sana Rehman, Lawrence J Sheplan

Pract Radiat Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
Rahul D Tendulkar, Grant K Hunter, Chandana A Reddy, Kevin L Stephans, Jay P Ciezki

Int J Radiat Oncol Biol Phys· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.
Trevor J Bledsoe, Anisha R Noble, Grant K Hunter, Lisa A Rybicki, Aaron Hoschar

Radiat Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
Ehsan H Balagamwala, Lilyana Angelov, Shlomo A Koyfman, John H Suh, Chandana A Reddy, Grant K Hunter

J Neurosurg Spine· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
Mohammad K Khan, Shlomo A Koyfman, Grant K Hunter, Chandana A Reddy, Jerrold P Saxton

Radiat Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of five or more brain metastases with stereotactic radiosurgery.
Grant K Hunter, John H Suh, Alwyn M Reuther, Michael A Vogelbaum, Gene H Barnett

Int J Radiat Oncol Biol Phys· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer.
Grant K Hunter, Chandana A Reddy, Eric A Klein, Patrick Kupelian, Kenneth Angermeier

Prostate Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to genetic manipulations of liver angiotensinogen in the physiological range.
Barbu Gociman, Andreas Rohrwasser, Elaine Hillas, Tong Cheng, Grant Hunter, Jennifer Hunter

J Hum Genet· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is daily CT image guidance necessary for nasal cavity and nasopharyngeal radiotherapy: an investigation based on helical tomotherapy.
Ke Sheng, Jennifer Chow, Grant Hunter, James Larner, Paul Read

J Appl Clin Med Phys· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of angiotensinogen in proximal tubule as a function of glomerular filtration rate.
Barbu Gociman, Andreas Rohrwasser, Pierre Lantelme, Tong Cheng, Grant Hunter, Jennifer Hunter

Kidney Int· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis